Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY)
Shanghai Pharmaceuticals Holding Co Ltd ADR is a depositary receipt listed on OTC Markets that represents the company’s common stock. The underlying issuer, Shanghai Pharmaceuticals Holding Co., Ltd., develops, manufactures, and sells pharmaceutical and healthcare products in China and overseas. Its operations are organized into Production, Distribution, Retail, and Other segments. The business portfolio includes chemical and biological drugs, traditional Chinese medicine, health products, and medical devices used across a range of therapeutic areas, including immunology, psychiatry, neurology, oncology, cardiovascular, digestive and metabolic conditions, respiratory diseases, and anti-infection treatments. The company also provides pharmaceutical distribution, warehousing, logistics, and related supply chain services to manufacturers, hospitals, distributors, and retail pharmacies, and it operates a network of retail pharmacy stores. Founded in 1994, the company is headquartered in Shanghai, China.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-SHPM.Y
|
$9.68
|
31.9% Upside
|
Undervalued
|
—
|
—
|
—
|
Good
|
July 16, 2026
|
September 14, 2026
|
0.24
|
5.0%
|
August 28, 2026
|
9.8x
|
0.7x
|
0.2x
|
8.266 B
|
11.605 B
|
45.3%
|
40.7%
|
6.3
|
52.8%
|
87.2%
|
